Top Buy
| Security ▼ | Buy | Sell | Buy (1M) | Sell (1M) | Price | Target price | Potential |
|---|---|---|---|---|---|---|---|
| Xencor Inc. | 10 | 1 | 0 | 0 | €20.00 | €32.58 | 62.895% |
| Viatris Inc. | 1 | 0 | 0 | 0 | €9.79 | - | - |
| United Therapeutics | 20 | 0 | 2 | 0 | €257.00 | €287.40 | 11.829% |
| Ultragenyx Pharmaceutical Inc. | 21 | 1 | 5 | 0 | €39.00 | €84.74 | 117.292% |
| Repligen Corp. | 13 | 0 | 0 | 0 | €134.95 | €184.76 | 36.910% |
| QIAGEN NV | 8 | 0 | 0 | 0 | €40.47 | €47.44 | 17.223% |
| PTC Therapeutics Inc. | 15 | 8 | 2 | 3 | €34.60 | €41.51 | 19.978% |
| Perrigo Co. plc | 3 | 0 | 0 | 0 | €24.95 | €35.99 | 44.230% |
| Novocure Ltd | 1 | 1 | 0 | 0 | €19.95 | - | - |
| Neurocrine Bioscience | 31 | 0 | 4 | 0 | €125.20 | €140.60 | 12.303% |
| Nektar Therapeutics | 3 | 1 | 0 | 0 | €1.15 | €3.70 | 222.862% |
| MorphoSys AG | 7 | 0 | 0 | 0 | €68.00 | €65.00 | -4.412% |
| Medpace Holdings Inc | 11 | 0 | 2 | 0 | €377.60 | €419.64 | 11.133% |
| Jazz Pharmaceuticals plc | 25 | 0 | 2 | 0 | €101.40 | €184.53 | 81.982% |
| Icon plc | 21 | 0 | 4 | 0 | €297.30 | €324.79 | 9.246% |
| Hutchison China MediTech Ltd ADR | 5 | 0 | 0 | 0 | €17.30 | €45.10 | 160.665% |
| Horizon Pharma plc | 4 | 0 | 0 | 0 | €110.40 | - | - |
| Halozyme Therapeutics Inc. | 18 | 0 | 4 | 0 | €47.57 | €49.59 | 4.236% |
| Exelixis Inc. | 18 | 0 | 0 | 0 | €20.57 | €26.01 | 26.429% |
| Canopy Growth Corp | 4 | 0 | 0 | 0 | €0.47 | €1.75 | 273.134% |
| Blueprint Medicines Corp | 1 | 0 | 0 | 0 | €95.60 | - | - |
| Ascendis Ph.sp.adr 1 Dk 1 | 1 | 0 | 0 | 0 | €123.00 | €150.00 | 21.951% |